SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-042376
Filing Date
2019-07-17
Accepted
2019-07-17 16:24:57
Documents
2
Period of Report
2019-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1657
2 POA DOCUMENT poa.txt EX-24.3_865247 3784
  Complete submission text file 0001209191-19-042376.txt   6833
Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Issuer) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 501 CANAL BLVD. POINT RICHMOND TECH CENTER RICHMOND CA 94804
Business Address
Conner Edward R. (Reporting) CIK: 0001691265 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37833 | Film No.: 19959383